Philippou, Yiannis
Sjoberg, Hanna T.
Murphy, Emma
Alyacoubi, Said
Jones, Keaton I.
Gordon-Weeks, Alex N. http://orcid.org/0000-0003-2997-4194
Phyu, Su
Parkes, Eileen E.
Gillies McKenna, W.
Lamb, Alastair D.
Gileadi, Uzi
Cerundolo, Vincenzo
Scheiblin, David A.
Lockett, Stephen J.
Wink, David A.
Mills, Ian G.
Hamdy, Freddie C.
Muschel, Ruth J.
Bryant, Richard J.
Article History
Received: 28 March 2020
Revised: 18 May 2020
Accepted: 4 June 2020
First Online: 9 July 2020
Ethics approval and consent to participate
: No patient-derived material was used in this study and thus there is no patient-specific ethical approval to report. Animal procedures were in accordance with UK Animal law (Scientific Procedures Act 1986), including local ethics committee (Clinical Medicine Old Road Campus Animal Welfare Ethical Review Body, University of Oxford) and UK Government Home Office approval. TRAMP-C1 (ATCC® CRL-2730™) and MyC-CaP (ATCC® CRL-3255™) cell lines were purchased from American Type Culture Collection (ATCC®).
: Not applicable.
: The authors agree to make the data in this paper publically available.
: The authors declare no competing interests.
: This work was funded by a Cancer Research UK/Royal College of Surgeons of England Clinician Scientist Fellowship (reference C39297/A22748) for R.J.B. and H.S., and by a research grant from The Urology Foundation for Y.P., along with a Cancer Research UK Clinical Research Training Fellowship for Y.P. The authors also acknowledge Federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. 75N91019D00024. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organisations imply endorsement by the U.S. Government. The authors are grateful to Cancer Research UK for support to the Cancer Research UK Oxford Centre.